The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| VAXCYTE INC | COM | 92243G108 | 18,108 | 832,166 | SH | DFND | 1 | 0 | 832,166 | 0 | |
| BOLT BIOTHERAPEUTICS INC | COM | 097702104 | 3,859 | 1,891,467 | SH | DFND | 1 | 0 | 1,891,467 | 0 | |
| INOZYME PHARMA INC | COM | 45790W108 | 12,694 | 2,661,154 | SH | DFND | 1 | 0 | 2,661,154 | 0 | |
| RALLYBIO CORP | COM | 75120L100 | 17,148 | 2,271,311 | SH | DFND | 1 | 0 | 2,271,311 | 0 | |
| KARUNA THERAPEUTICS INC | COM | 48576A100 | 111,513 | 881,458 | SH | DFND | 1 | 0 | 881,458 | 0 | |
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 12,126 | 569,041 | SH | DFND | 1 | 0 | 569,041 | 0 | |
| ALIGOS THERAPEUTICS INC | COM | 01626L105 | 899 | 743,215 | SH | DFND | 1 | 0 | 743,215 | 0 | |
| AKOUOS INC | COM | 00973J101 | 8,414 | 1,794,088 | SH | DFND | 1 | 0 | 1,794,088 | 0 | |
| VIGIL NEUROSCIENCE INC | COM | 92673K108 | 1,446 | 560,595 | SH | DFND | 1 | 0 | 560,595 | 0 | |
| FUSION PHARMACEUTICALS INC | COM | 36118A100 | 3,887 | 1,560,982 | SH | DFND | 1 | 0 | 1,560,982 | 0 | |
| EXSCIENTIA PLC | ADS | 30223G102 | 8,410 | 772,285 | SH | DFND | 1 | 0 | 772,285 | 0 | |